|
Originally published In Press as doi:10.1074/jbc.M003353200 on June 13, 2000
J. Biol. Chem., Vol. 275, Issue 33, 25641-25651, August 18, 2000
Characterization of Human RhCG and Mouse Rhcg as Novel
Nonerythroid Rh Glycoprotein Homologues Predominantly Expressed in
Kidney and Testis*
Zhi
Liu ,
Ying
Chen ,
Rong
Mo§,
Chi-chung
Hui§,
Jan-Fang
Cheng¶,
Narla
Mohandas¶, and
Cheng-Han
Huang
From the Laboratory of Biochemistry and Molecular
Genetics, Lindsley F. Kimball Research Institute, New York Blood
Center, New York, New York 10021, the § Program in
Developmental Biology, The Hospital for Sick Children and Department of
Molecular and Medical Genetics, University of Toronto,
Toronto, Ontario M5G 1X8, Canada, and the ¶ Life Sciences
Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720
Received for publication, April 19, 2000, and in revised form, May 23, 2000
 |
ABSTRACT |
In mammals, the Rh family includes the variable
Rh polypeptides and invariant RhAG glycoprotein. These polytopic
proteins are confined to the erythroid lineage and are assembled into a multisubunit complex essential for Rh antigen expression and plasma membrane integrity. Here, we report the characterization of RhCG and
Rhcg, a pair of novel Rh homologues present in human and mouse nonerythroid tissues. Despite sharing a notable similarity to the
erythroid forms, including the 12-transmembrane topological fold, the
RHCG/Rhcg pair is distinct in chromosome location, genomic organization, promoter structure, and tissue-specific expression. RHCG and Rhcg map at 15q25 of human chromosome
15 and the long arm of mouse chromosome 7, respectively, each having 11 exons and a CpG-rich promoter. Northern blots detected kidney and
testis as the major organs of RHCG or Rhcg
expression. In situ hybridization revealed strong
expression of Rhcg in the kidney collecting tubules and
testis seminiferous tubules. Confocal imaging of transiently expressed
green fluorescence protein fusion proteins localized RhCG
exclusively to the plasma membrane, a distribution confirmed by
cellular fractionation and Western blot analysis. In vitro translation and ex vivo expression showed that RhCG carries
a complex N-glycan, probably at the
48NLS50 sequon of exoloop 1. These results
pinpoint RhCG and Rhcg as novel polytopic membrane glycoproteins that
may function as epithelial transporters maintaining normal homeostatic
conditions in kidney and testis.
 |
INTRODUCTION |
The Rh antigens, originally identified in human red blood cells
(RBCs),1 are potent
immunogens and, when incompatible, cause hemolytic disease of the
newborn and blood transfusion reaction (1). They are defined by two
erythroid-specific transmembrane (TM) proteins, the Rh polypeptides and
the Rh-associated glycoprotein (RhAG), which form a multisubunit
complex and display exodomains as D or CcEe antigens (2). The Rh
polypeptides are highly polymorphic and are distinguished from RhAG by
two biochemical features, i.e. palmitoylation but no
glycosylation. In contrast, RhAG is largely invariant at the population
level and is thought to modulate the assembly of the Rh complex and its
surface expression. Human Rh polypeptides and RhAG are encoded by
RHCED and RHAG loci that reside on chromosomes 1 and 6, respectively (3, 4). Despite this difference, these
RH genes have originated from a common ancestor during
evolution in that they are homologous in coding sequence and are
grossly similar in exon/intron organization (5, 6).
Although their exact functions remain to be identified, Rh proteins
(and their complex) are necessary for the maintenance of RBC morphology
and plasma membrane integrity. The Rh deficiency syndrome, a rare
inherited form of hemolytic anemia, is caused by mutations at the
RHAG or RHCED locus (2). In this disorder, RBCs
deficient in all Rh antigens exhibit spherostomatocytosis and multiple
membrane abnormalities (7), implying that Rh proteins have some
functional roles in membrane physiological processes. At the level of
secondary structure, RhAG and RhCE/D bear a 12-TM topology resembling
many transporters (8) and thus are likely to possess a transporter
activity across the lipid bilayer. Ammonium or amino
group-containing compounds have been suggested as candidate ligands for
erythroid Rh proteins, owing to their connective sequence similarity
with the NH4+ transporters from
bacteria, yeast, and plants (2, 9).
The Rh family of genes and proteins is rooted deeply in evolution, and
the erythroid homologues of human RHAG and RHCED
genes are coexpressed in RBC of all mammalian species. The closest
RHAG and RHCED relatives are those from nonhuman
primates, as they share not only high sequence identity but also some
antigen reactivity (10, 11). We previously showed that the mouse
erythroid Rhag and Rhced are identical to their
human counterparts in the arrangement of exon/intron junctions, in the
conservation of chromosome synteny, and in the pattern of coexpression
(12). Furthermore, Rh homologues have been identified in primitive
organisms, e.g. the unicellular slime mold
Dictyostelium discoideum (2), marine sponge Geodia cydonium (13), and earthworm Caenorhabditis elegans
(14, 15). Structurally, these primitive Rh forms are more similar to
RhAG than they are to RhCE/D, providing some important insights into the origin of erythroid members from nonerythroid ancestors. However, it is not known whether these Rh homologues in primitive organisms had
branched out, giving rise to new family members expressed in
nonerythroid tissues or organs of vertebrate species.
To understand the structure-function relationships of Rh proteins, we
have been using a homology approach to clone and identify new Rh genes
from lower organisms and from nonerythroid tissues. We describe here
the characterization of Rh type C glycoproteins, human RhCG and mouse
Rhcg, two orthologous members of the Rh protein family expressed in
nonerythroid tissues. We show that RhCG and Rhcg share with their
erythroid counterparts the conserved 12-TM topology and cognate
signature sequences. However, as the first vertebrate members
recognized in the nonerythroid Rh subfamily, RhCG and Rhcg are distinct
in primary structure, genomic organization, chromosomal location,
tissue-specific expression, and biochemical properties. The studies
detailed herein pinpoint RhCG and Rhcg as novel polytopic membrane
glycoproteins that may function as epithelial transporters maintaining
normal homeostatic conditions in the kidney and testis.
 |
MATERIALS AND METHODS |
Cloning of Mouse Rhcg and Human RHCG cDNAs--
Using mouse
Rhag cDNA (12) for a BLAST search (16), a mouse testis
expressed sequence tag (AA063867) of high homology was detected. Sense
(s) or antisense (a) gene-specific primers (GSPs) were designed to
obtain full-length Rhcg cDNA. For 5'-RACE (17), 1 µg of mouse testis total RNA was primed with GSP-E7a (GAAGGAATGGACTATCCCTGGCTC). The cDNA was tailed with dCTP using the
supplier's protocol (Life Technologies, Inc.) and amplified by
two-round PCR with supplied adapter primers and GSPs (E6a1, GGTGGAGAAAATGCCGCAGAA; E6a2, AACCCCACGATGAGAGCGCCGTAA). A 1.1-kb cDNA was purified and sequenced; 3'-RACE (17) was similarly carried
out with GSPs (E7s1, CCATTCCTGGAGTCCCGCCTT; E7s2,
CGCATCCAGGACACATGTGGCA). To clone RHCG, degenerate primers
(RhCG-d1, TC(C/T)ATGAC(C/T)ATCCA(C/T)ACATT(C/T)GG; RhCG-d2,
CAG(A/G)TT(A/G)TG(A/G)ATGCC(A/G)CATGTGTC) corresponding to
conserved Rhcg regions (codons 182-189 and 337-344) were
used in reverse transcription-PCR of human kidney total RNA. A 480-bp cDNA was purified and sequenced. After comparison with
Rhcg open reading frame, GSPs were designed and used to
derive full-length RHCG cDNA, as described above.
Other molecular biological procedures followed standard
methods (18).
Comparison of RhCG, Rhcg, and Other Homologues--
The amino
acid sequences of RhCG, Rhcg and other Rh homologues were aligned by
means of Clustal W (19) (MegAlign software, DNASTAR). The
hydropathy plots were obtained using the Kyte-Doolittle method
(20).
RHCG Expression Constructs--
The full-length RHCG
cDNA was cloned in pCR2.1 vector (Invitrogen) using the following
GSPs: E10a(XhoI),
CCGCTCGAGCTAGGGTACCAAGGGTACCGA; E1s(BglII), GAAGATCTAGCATGGCCTGGAACACCA.
All constructs were derived from this master template with
Pfu DNA polymerase and were verified to be free of mutations
by sequencing. To tag the green fluorescence protein (GFP), RHCG was
amplified by GSP-E1s(BglII) plus E10a(XhoI) or
E1s(BglII) plus E10a(SalI) and subcloned in the
pEGFP-C1 or pEGFP-N3 vector (CLONTECH). For
translation and expression studies, RHCG was cloned in pYES2
or pcDNA3.1/MycHisA (Invitrogen) by BamHI and
XhoI double digestion. To express the RhCG C-tail (amino
acids 417-479), its coding region was amplified by
GSP-E9s(BamHI) (CGGGATCCAGATTACCATTCTGGGGAC) plus E10a (XhoI) and cloned separately into vectors
pGEX-4T-1 (Amersham Pharmacia Biotech) and pET30a(+) (Novagen).
Production of Polyclonal Antisera for RhCG C-tail--
The RhCG
C-tail was expressed in E. coli BL21 (0.3 mM
isopropylthio- -galactoside at 30 °C for 4 h) as a
glutathione S-transferase fusion protein or a
His6-tagged peptide. After sonication, glutathione S-transferase-RhCG was purified on glutathione Sepharose 4B,
and ~300 µg was emulsified with adjuvant and injected into rabbits five times (21). Antisera were affinity-purified by passing through a
glutathione S-transferase column (Pierce) and then a Ni-NTA column (Qiagen) bound with His-tagged RhCG tail. After washing,
the antibodies were eluted with 4 M MgCl2 and
dialyzed in 1× phosphate-buffered saline at 4 °C. The IgG fractions
showed binding to recombinant RhCG C-tails only.
Screening of Genomic Clones and Definition of Exon/Intron
Boundaries--
Bacterial artificial chromosome (BAC) clones of
RHCG or Rhcg were screened by PCR. The GSPs for
RHCG (E6s, CGTGGGTACCGCTGCTGAGAT; E7a,
TATGATGCCAGGAATGCCATGCAG) gave a 360-bp band. The GSPs for Rhcg (E6s, GCTCTCATCGTGGGGTTCTTCTGC; E7a,
CAGGTTGTGRATGCCACATGTGTC) gave a 310-bp band. BAC DNA was fingerprinted
by exon PCR and mapped by Southern blotting. Exon/intron boundaries
were amplified in two steps from genomic libraries (5, 12) and
sequenced. Exon/intron junctions were defined by alignment with
cDNA sequences. Introns were amplified from BAC DNA, and their
sizes were estimated by gel electrophoresis.
5'-RACE and 5' Genomic Walking--
5'-RACE was performed as
mentioned above. The 5' region of RHCG or Rhcg
gene was amplified from the human or mouse genomic libraries (5, 12)
using adaptor primers and exon 1 GSPs. The PCR products were purified
and sequenced.
Chromosomal Mapping of RHCG and Rhcg Genes--
Fluorescence
in situ hybridization to interphase chromosomes (22) was
used to map human RHCG. The DNA from BAC clone 300M8 or
2160I19 was labeled as probes. Rhcg was assigned using
Jackson BSS interspecific backcross ((C57BL/6JEiXSPRET/Ei)F1XSPRET/Ei) (23). The HhaI restriction site was present in
Rhcg intron 4 of C57BL/6JEi but not in intron 4 of SPRET/Ei.
Rhcg linkage was defined by HhaI digestion of
intron 4 fragments in all 94 progenies amplified with GSPs
(CTCACAGTGACCTGGATCCTCTAC and CATATCCAACTTGCCCTTCTTGTG).
Northern Blot Analysis and RNA in Situ Hybridization--
Two
sets of Northern blots (CLONTECH) were hybridized
to RHCG or Rhcg cDNA. The RHCG
(codon 250-437) and Rhcg (codon 194-377) probes were 563 and 552 bp in size, respectively. As a control, the -actin probe was used.
RNA in situ hybridization to mouse embryos and tissues was
carried out using standard protocols, as described (24). A 384-bp sequence covering the 3' region of Rhcg cDNA
(nucleotides 1110-1494) was subcloned in pCRScript Sk(+) vector
(Stratagene) and used to prepare 33P-labeled probes. The
antisense and sense probes were generated by in vitro
transcription of the BamHI- and NotI-linearized
Rhcg plasmids by T7 and T3 RNA polymerases, respectively.
Transfection of RHCG cDNA and Confocal Imaging of RhCG
Protein--
HEK293 and HeLa cells (ATCC) were grown at 37 °C in
Dulbecco's modified Eagle's medium containing 10% fetal calf serum
(Life Technologies, Inc.) under 5% CO2. After 24 h,
cells were transferred to either a six-well plate or cover glass and
transfected by LipofectAMINE (Life Technologies, Inc.). For transient
expression, 1 µg of RHCG cDNA was used to transfect
3 × 105 HEK293 or HeLa cells.
For stable selection, RHCG.myc/HisA plasmid (1 µg,
PvuI cut) was used to transfect 3 × 105
HEK293 cells/well in a six-well plate. Stable cell lines were selected
in Dulbecco's modified Eagle's medium (G418, 800 µg/ml) and
clonally isolated by standard procedures (18). For confocal imaging, 1 µg of RhCG-GFP or GFP-RhCG plasmid was transfected in 3 × 105 HEK293 or HeLa cells plated onto a 35-mm
coverglass (MatTek) and cultured for 24 h. GFP was excited
at 488 nm with an argon laser, and the light emitted between 506 and
538 nm was recorded for fluorescein isothiocyanate filter.
Images were collected using a Bio-Rad MRC 600 confocal scan head on a
Nikon Eclipse 200 microscope with a 60XN.A.1.4 planapo infinity
corrected objective. The captured three-dimensional images were
processed with Adobe Photoshop (version 4.0).
In Vitro Translation and N-Glycosylation--
To define the
biochemical features of RhCG, in vitro translation and
posttranslational processing were carried out. As templates, RhCG
plasmids of pYES or pcDNA3.1/MycHisA were used in a
transcription-coupled translation system (Promega) with
[35S]methionine (15 mCi/ml, Amersham Pharmacia
Biotech). Labeled RhCG was analyzed by 12% SDS-PAGE (25) after
incubation with or without canine pancreatic microsomal membranes
(CPMM) (Promega).
Western Blot and N-Glycanase Analysis of RhCG--
Cellular
fractionation and isolation of membrane vesicles from stable HEK293
cells were done as described with minor modification (26). Protein was
resuspended at 1 mg/ml in ice-cold buffer (10 mM HEPES, pH
7.5, 1 mM MgCl2, 250 mM sucrose).
RBC ghosts were prepared as described (27). 8 µg of HEK293 membranes
and 50 µg of RBC membranes, treated with or without PNGase F (New England BioLabs), were analyzed by 12% SDS-PAGE (25). Western blots
were probed by purified anti-RhCG (1:1, 500) or horseradish peroxidase-conjugated anti-Myc monoclonal antibody (1:5,000)
(Invitrogen). The anti-RhCG probed blot was stained with horseradish
peroxidase-linked donkey anti-rabbit IgG (1:5,000) (Amersham Pharmacia
Biotech) and visualized by a chemiluminescent kit (Pierce). The
anti-Myc probed blot was visualized directly with the above detection system.
 |
RESULTS |
Nucleotide Sequences of RHCG and Rhcg
cDNAs--
Sequencing revealed that RHCG and
Rhcg cDNAs, 1952 and 2097 bp long, respectively, share
an overall 68.8% identity at the nucleotide level, forming an
orthologous pair. The variation in the sequence is mainly in the 5'-UTR
and 3'-end of open reading frames (Fig.
1). RHCG and Rhcg
have a consensus polyadenylation signal but lack the typical Kozak
sequence (28) and stop codon preceding the first in-frame AUG codon,
two features common to the erythroid Rh genes (5, 12). However,
RHCG and Rhcg are G/C-rich (RHCG,
57.5%; Rhcg, 55.4%; versus RHAG,
42.6%; Rhag, 41.8%) and have completely different 5'- and
3'-UTR sequences.

View larger version (102K):
[in this window]
[in a new window]
|
Fig. 1.
The complete cDNA and predicted amino
acid sequences of human RhCG (AF193809) and mouse Rhcg (AF193810)
proteins. The sequences are aligned using the Clustal W program.
Amino acid changes of similar nature are shown in boldface,
and those of different nature are circled. Deletions are
denoted by dashes. The N-glycosylation motifs in
RhCG are overlined, and those in Rhcg are
underlined. Nucleotide and amino acid numbers are counted by
reference to the first position of ATG codon as +1. The polyadenylation
signal AATAAA in the 3'-UTR of the two genes is
underlined.
|
|
The Primary Structure and Predicted Topology of RhCG and Rhcg
Proteins--
The open reading frame of human RHCG encodes
a 53-kDa, 479-amino acid polypeptide, whereas that of mouse
Rhcg encodes a 55-kDa, 498-amino acid polypeptide (Fig. 1).
The RhCG and Rhcg proteins are highly conserved, sharing 77.2%
identity and 90.4% similarity with regard to their primary structures.
RhCG differs from Rhcg by three small deletions: one serine at position
51 and two amino acid stretches in the extreme C-terminal region are
absent in RhCG (Fig. 1). The majority of variations are conserved amino acid changes, with ~50% of them being clustered at the C-terminal positions of 360/361.
The RhCG (pI = 6.2) and Rhcg (pI = 6.5) proteins are
negatively charged at physiologic pH and are composed mainly of
hydrophobic (44%) and polar (25%) amino acids. Hydropathy analysis
(20) showed that they share identical topology and charge distribution, each spanning the lipid bilayer 12 times, with both N and C termini facing the cytoplasm (Fig. 2). The 12-TM
fold and its cognate signatures, including the charged residues
(Asp129 and Glu166), are conserved and
reminiscent of other homologs, i.e. the RhAG/Rhag (4, 12)
and RhBG/Rhbg pairs (Fig.
3).2
However, RhCG and Rhcg are distinct in that they have a much elongated
C-terminal segment and unique N-terminal and exoloop sequences. There
are also three N-glycosylation NX(S/T) motifs in
RhCG and two in Rhcg (Fig. 1), suggesting that these proteins are
expressed as polytopic glycoproteins. Nevertheless, except for
48NLS50 (RhCG) (Fig. 2) or
48NIS50 (Rhcg), other NX(S/T) motifs
were predicted to reside in the TM or in the cytoplasmic domain and
thus are unlikely to become glycosylated in vivo.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
The membrane topology and charge distribution
of RhCG. Human RhCG and mouse Rhcg show a nearly identical
hydropathy profile as calculated in Kyte-Doolittle scale. For brevity,
only the model for RhCG is shown. The 12-TM helices and their amino
acid positions defining the boundary are indicated. Different
circles denote groups of amino acids: solid
circles, hydrophobic Phe, Ile, Leu, Met, Val, and Trp;
gray circles, Gly, Ala, and Pro; open circles,
polar Ser, Cys, Thr, Asn, Gln, and Tyr; +, positively charged Lys, Arg,
and His; and -, negatively charged Asp and Glu. The only
N-glycosylation site present in the first exo loop is
illustrated.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
Percentage of identity and phylogenetic
relationship between RhCG/Rhcg and other homologs. Upper
panel, percentage of identity of protein sequences of the various
Rh homologs obtained by MegAlign. Boxed area shows the
percentage of identity of the human and mouse orthologous pairs.
Lower panel, phylogenetic tree of the Rh family of proteins.
Organisms are as follows: Hs, Homo sapiens;
Mm, Mus musculus (house mouse); Dr,
Danio rerio (zebrafish); Gc, G. cydonium (marine sponge); Ce, C. elegans
(nematode); Dm, Drosophila melanogaster (fruit
fly); and Dd, D. discoideum (slime mold). Note
that both RhCG/Rhcg and RhBG/Rhbg belong to the nonerythroid group, as
they merge at the same branch point. The GenBankTM
accession numbers are as follows: Hs.RHBG, AF193807; Mm.Rhbg, AF193808;
Hs.RHCG, AF193809; Mm.Rhcg, AF193810; Hs.RHAG, AF031548; Mm.Rhag,
AF057526; Hs.RHD, L08429; Hs.RHCE, X54534; Mm.Rhced, AF057524; Dr.Rhg,
AF209468; Gc.Rhg, Y12397; Ce.Rhp-1, AF183390; Ce.Rhp-2, AF183391;
Dm.Rhp, AF193812; and Dd.RhgA, AF193811.
|
|
Relationship of RhCG/Rhcg with Other Rh Protein
Homologs--
Along with the identification of RhCG and Rhcg, we also
isolated cDNAs encoding new Rh homologues from model organisms and nonerythroid tissues.2 Multiple sequence alignment yielded
a dendrogram in which the known Rh homologues are clustered in three
distinct groups: primitive, erythroid, and nonerythroid (Fig. 3). RhCG
and Rhcg were placed as a pair in the nonerythroid subgroup that also
includes Hs.RhBG, Mm.Rhbg, Dr.Rhg, and Gc.Rhg. All these proteins are
polytopic glycoproteins that are likely to contain a single
N-glycan on their exoloop 1.
As shown by pairwise sequence comparison, RhCG and Rhcg are most
closely related to the nonerythroid RhBG/Rhbg pair (51.7-54.5% identity)3 and erythroid
RhAG/Rhag pair (45.4-50.9% identity) (Fig. 3). This degree of overall
identity is largely attributable to conserved TM segments (particularly
TM2-11) and their immediately adjacent amino acids, suggesting that
these domains define an important function. Significantly, both RhCG
and Rhcg are much less similar to antigen carriers, RhCE/D, or
Rhced (24.4-28.5% identity). Considering their relationship
with the primitive subgroup, RhCG and Rhcg are more closely related to
the fruit fly homologue Dm.Rhp, with which they share a 37%
overall sequence identity (Fig. 3). These results suggest that the
RHCG/Rhcg pair originated from early primitive gene
precursors and was subjected to an independent evolutionary pathway
following its duplication and separation from erythroid members.
Chromosomal Location of RHCG and Rhcg Genes--
The chromosomal
location of the human RHCG gene was mapped by fluorescence
in situ hybridization using the two BAC genomic clones as
probes. The result showed that RHCG is located at 15q25 of
chromosome 15 (Fig. 4A). Using
RHCG as a query for BLAST search, we detected an exactly
matched expressed sequence tag (G75833) from the human CEPH YAC clone
that had been mapped at 15q26 (29). These data establish a separate
location of RHCG from the erythroid RHCED and
RHAG loci that are mapped at chromosomes 1p34-36 and 6p11-21.1, respectively (3, 4).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
Chromosomal location of human RHCG
and mouse Rhcg. A, diagram for
the location of RHCG at 15q25. DNAs purified from
RHCG BAC clones 300M8 and 2160I19 were used as fluorescence
in situ hybridization probes and gave the same result.
B, Rhcg map on chromosome 7 (the centromere
toward the top). A 3-cM scale bar is indicated.
Loci mapping to the same position are listed in alphabetical order.
Corresponding human map positions for underlined loci are listed to the
left of the chromosome bar.
|
|
The mouse Rhcg gene was mapped by linkage analysis (Fig.
4B). Rhcg is nonrecombinant to the
D7Xrf229 locus, with an LOD score of 28.3. This linkage placed Rhcg distal to Gnb2-rs1 but
proximal to Pcsk3 on the long arm of chromosome 7, a region
showing conserved synteny with human 15q25 containing RHCG
gene (Fig. 4A). Notably, this locus map is also separate
from the erythroid Rhced and Rhag loci that are
localized to chromosomes 4 and 17, respectively (12).
Genomic Organization and Exon/Intron Structures--
BAC clones
retaining human RHCG or mouse Rhcg gene were
isolated and characterized in order to delineate their structural organization. As shown in Fig. 5, the two
genes share a nearly identical organization, each having 11 exons that
range from 74 to 187 bp and 10 introns that range from 0.2 to 8.8 kb.
In both RHCG and Rhcg genes, exon 11 occurs as a
noncoding 3'-UTR segment, a unique feature that distinguishes from all
other Rh homologs. Their internal exons 2-9 are identical in size, and
their exons 2-6 are arranged in the same fashion as exons 2-6 of
RHAG and Rhag genes (Fig. 5). Because exons 2-6
encode TM2-9 domains in both erythroid and nonerythroid homologs,
their conservation in sequence and size implies strict control of the
length of the corresponding TM domains and flanking loops.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
Organization of human RHCG
and mouse Rhcg genes and comparison with the
erythroid RHAG and Rhag genes.
The size of exons (E1-E11) is counted in base pairs, and that of
introns is counted in kilobase pairs. The noncoding exon for the 3'-UTR
downstream of the stop codon in each gene is shaded. The
human RHCG GenBankTM accession numbers are
AF219981-AF219986. The human RHAG GenBankTM
accession numbers are AF238372-AF238377.
|
|
Fig. 6 shows the sequences of
RHCG and Rhcg genes containing splice sites and
exon/intron junctions. All 5' donor and 3' acceptor sites conform to
the "GT-AG" rule and show consensus to the primate and
rodent gene splicing signals (30). Of the 10 coding exons assigned, all
but exons 6 and 10 are asymmetrical containing one (exons 1, 3, 4, 5, 7, and 9) or two (exons 2 and 8) split intercodons at the 5' and/or 3'
exon/intron junction. The amino acids encoded by exon/exon boundaries
are the same between RhCG and Rhcg, except for four conserved changes
(Fig. 6). Such a division of coding exons is observed in mammals
(10-12) but not in more primitive organisms (data not shown).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 6.
Assignment of splice sites and exon/intron
junctions between RHCG and Rhcg.
Exons are in uppercase letters, and interval sequences are
omitted. Acceptor and donor splice sites are in lowercase
letters. Amino acids encoded by exon borders are listed.
Stars denote the stop codon and polyadenylation signal. Note
that exon 11 encodes no amino acid sequence.
|
|
Proximal Promoter Sequence and Transcription Start
Site--
Genomic walking revealed that the 5' region upstream of the
first ATG codon of RHCG or Rhcg contains multiple
cis-acting elements known to bind various transcription
factors (Fig. 7). This proximal sequence
is highly enriched in CpG dinucleotides (39 CpGs out of 443 bp for
RHCG and 25 CpGs out of 279 bp for Rhcg), a
hallmark of CpG islands that often overlap with generic promoters (31). The sequence is also highly asymmetrical in strand composition alternating with pyrimidine and purine stretches. Notably, these features and many cis-acting motifs are absent from
erythroid RH promoters (5, 6, 12, 32-34).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 7.
Nucleotide sequences of the 5' region of
human RHCG and mouse Rhcg genes.
A, RHCG; B, Rhcg. Potential cis-acting motifs
known to bind to the various transcription factors are
boxed, and their orientation is indicated above
(sense) or below (antisense) the sequences. CpG
dinucleotides are clustered in the region and are shown in
boldface. The major transcription start site (-24A in
RHCG and -122A in Rhcg) is denoted by a
bent arrow. The first position of ATG initiation codon is
numbered +1. The partial amino acid sequence of exon 1 is shown.
|
|
Sequencing of the 5'-RACE products identified -24A and -126A as the
major transcription start sites in the RHCG and
Rhcg genes, respectively (Fig. 7). The sites were determined
by using total RNA isolated from the human kidney and mouse testis
tissues, and this mapping result was consistent with the beginning of
5'-UTR sequence observed in the full-length cDNAs (Fig. 1). The
fact that no in-frame ATG occurs in the genomic sequence further
upstream of the transcription start site (Fig. 7) also supports the
predicted AUG codon as the translation initiation signal (Fig. 1).
Tissue Expression of RHCG and Rhcg--
The expression of
RHCG and Rhcg was assessed by Northern blot
analysis (Fig. 8) and by in
situ hybridization (Fig. 9). In human adult tissues, a 2.0-kb RHCG transcript was found
abundantly expressed in the kidneys and also in the brain, testis,
placenta, pancreas, and prostate (Fig. 8A). (Its apparent
lower expression in the testis was probably caused by an uneven
sampling of testicular tissues for poly(A)+ RNA preparation.) In human
fetal tissues, the kidney was the only organ found to express
RHCG transcripts. In mouse adult tissues, Rhcg
was shown to be also highly expressed in kidney and testis but not in
other tissues, e.g. brain (Fig. 8B). Furthermore,
no Rhcg transcript was detected in embryos of 7-19 days of
gestation nor in erythroid tissues (data not shown). Taken together,
the results indicate that RHCG or Rhcg is largely expressed at very late stages of development and with limited tissue
specificities.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 8.
Northern blot analysis. A,
RHCG expression in human adult and fetal tissues.
B, Rhcg expression in mouse adult tissues. The
size marker is indicated. Tissues are denoted above each
panel. s. muscle, skeletal muscle; s. intestine,
small intestine. Each lane was loaded with 2 µg of poly(A)+ RNAs. The
2.0-kb major band is indicated with an arrow. The actin
cDNA hybridization with these blots was relatively uniform (data
not shown for brevity).
|
|

View larger version (128K):
[in this window]
[in a new window]
|
Fig. 9.
Rhcg expression in adult mouse testis and
kidney. A, in situ RNA hybridization with a
sense control probe. B, strong Rhcg expression is
detected in adult mouse testis. C, high magnification of the
boxed area in B showing expression in the
seminiferous tubules (indicated by arrow).
D, strong Rhcg expression was detected in mouse
adult kidney. E and F, high magnifications
showing Rhcg expression in the kidney collecting tubules
(arrowheads). A-E, dark field microphotographs;
F, bright field microphotograph.
|
|
The results from RNA in situ hybridization further helped
refining of the sites of Rhcg expression in mouse tissues
(Fig. 9). In mouse testis, Rhcg was abundantly expressed in
the seminiferous tubules (Fig. 9B), the main components of
the adult testicle that produce spermatozoa (35). Higher
magnification revealed that the Rhcg signals decorated the
complex stratified epithelium (Fig. 9C), a lining of the
seminiferous tubules known to contain spermatogenic cells and
supporting Sertoli cells (35). In mouse kidney, Rhcg was
broadly and abundantly expressed in both the renal cortex and the
medulla (Fig. 9D). The signals exhibited a radially
distributed pattern along their length that corresponded to the
parallel alignment of the myriad minute uriniferous tubules that form
the functional renal units (35). At higher magnification, the
Rhcg signal was primarily confined to the epithelial linings
of the collecting tubules (Fig. 9, E and F).
These results point toward specific expression of Rhcg in
the tubular structures of the testis and the kidney.
Cellular Localization of RhCG by Confocal Imaging
Analysis--
Confocal microscopy (Fig.
10) revealed that the fluorescence
signal was confined to the plasma membrane of cells transfected with
RhCG-GFP constructs (B, C, E, and F), whereas it
was evenly distributed in the cytoplasm of cells transfected with GFP
vector alone (A and D). The membrane localization
was not dependent on the orientation of GFP in the fusion constructs or
on the type of cells used in the transfection assay. These results
imply that the RhCG protein is normally destined to the plasma
membrane.

View larger version (106K):
[in this window]
[in a new window]
|
Fig. 10.
Localization of RhCG to the plasma membrane
by confocal microscopy. Cultured HEK293 or HeLa cells were
transfected with either RHCG-GFP (cloned in pEGFP-N3) or
GFP-RHCG fusion plasmid (cloned in pEGFP-C1). Images were
collected on a Bio-Rad MRC confocal laser scanning microscope. The
panels are designated as follows: A-C, homologous HEK293
cells; D-F, heterologous HeLa cells; A and
D, positive controls (pEGFP-N3 vector alone); B
and E, RHCG-GFP fusion construct; C
and F, GFP-RHCG fusion construct.
|
|
In Vitro Translation and N-Glycosylation of RhCG Protein--
To
assess ER translocation and early processing events during
biosynthesis, RhCG was translated in vitro, in either the
absence or presence of CPMM, and analyzed by SDS-PAGE. In the absence of CPMM, in vitro translated RhCG, with or without a c-Myc
tag, migrated as a single band with a molecular mass less than the predicted molecular mass of 53 kDa (Fig.
11A). This mobility anomaly is also seen in erythroid homologues and is most likely the result of
the highly hydrophobic nature of these proteins (36). In the presence
of CPMM, the RhCG proteins exhibited a slower migration pattern
suggesting that they may be differentially glycosylated (Fig.
11B). The observed size differences between the CPMM-treated and untreated protein products can be accounted by the size of a single
complex N-glycan. These in vitro studies
indicated that RhCG could be glycosylated.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 11.
In vitro transcription-coupled
translation and N-glycosylation analysis of RhCG
protein. A, analysis of in vitro translation
products by 12% reducing SDS-PAGE in the absence of CPMM. Lanes
1-4 are positive and negative controls: lane 1, yeast
-mating factor; lane 2, luciferase; lane
3, DNA omitted; lane 4, pYES2 vector. Lane
5, pYES2/RhCG. Lane 6, pcDNA3.1/RhCG-Myc tag.
B, analysis of in vitro translation products by
reducing 12% PAGE after incubation with CPMM. Lane 1, yeast
-mating factor; lane 2, DNA omitted; lane 3, pYES/RhCG; lane 4, pcDNA3.1/RhCG-Myc tag. Note the
up-shift of RhCG in B. Molecular mass markers (in
kDa) are indicated at the left margin.
|
|
Western Blot and N-Glycanase Analysis of RhCG Protein--
To
establish the in vivo expression of RhCG as a glycoprotein,
membrane proteins were isolated from HEK293 cells stably transfected with the RHCG.myc/His construct. Western blots probed
with the RhCG C-tail polyclonal antiserum showed a major protein band
with a molecular mass of ~58 kDa (Fig.
12A, lanes 3 and
4); this size was slightly larger than that of in
vitro glycosylated RhCG (Fig. 11B, lane 4). After
N-glycanase treatment, the size of membrane-bound RhCG was
decreased to 46 kDa (Fig. 12A, lanes 5 and 6),
which was equivalent to that of in vitro translated but
unglycosylated RhCG (Fig. 11A, lane 6). This result
indicated that the same AUG initiation codon could be used for RhCG
synthesis in both in vivo and in vitro. Because
the stably expressed RhCG protein was expected to carry a Myc/His tag
at the C-terminal end, anti-Myc monoclonal antibody was used to probe
the same Western blots. This analysis revealed the same banding pattern
(Fig. 12B), confirming that RhCG exists as a membrane
glycoprotein of which the N-glycan is most probably attached
to the 48NLS50 sequon on exoloop 1 (Fig.
2).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 12.
Western blot analysis and
N-glycanase treatment of membrane RhCG. Plasma
membrane proteins were prepared from stable HEK293 cells, fractionated
by 12% SDS-PAGE, and blotted onto Hybond NC membranes. RhCG was
visualized either by RhCG tail-specific antisera (A) or by
anti-Myc monoclonal antibody (B). Dilution of the two
antibodies is shown. Human RBC membranes were used as controls
(lanes 1 and 2). + and - indicate the presence
and absence, respectively, of reducing agent dithiothreitol
(DTT) and N-glycanase PNGase.
HRP, horseradish peroxidase. Molecular mass markers
are shown at the left margin.
|
|
 |
DISCUSSION |
In the present study, we have isolated several new Rh genes and
performed detailed characterization of the human RHCG and mouse Rhcg genes encoding a novel pair of polytopic plasma
membrane glycoproteins. We showed that the RhCG and Rhcg cDNAs are
highly conserved with regard to their nucleotide and derived protein sequences and membrane topologic organization. These results firmly establish the genuine orthologous relationship between the two homologues, suggesting that they possess the same functional role(s) in
both human and mouse nonerythroid tissues. Clustal analyses of known Rh
homologues define RhCG and Rhcg as the first new members of the
nonerythroid Rh subfamily in vertebrate species, including all mammals.
The detailed studies concerning the genetic and biochemical aspects of
RhCG/Rhcg revealed common features as well as distinct differences
between the erythroid and nonerythroid Rh homologues. Collectively
these results provide novel insights into the molecular evolution,
structural conservation, tissue-specific expression, and possible
biological function of the Rh family of genes and proteins.
The many homologous sequences assembled suggests the existence of a Rh
superfamily, which to date consists of five and four discrete gene
members in humans and mice, respectively. Based on their genomic
synteny, sequence identity, and tissue specificity, the human and mouse
homologues can be divided into four orthologous groups, i.e.
two erythroid gene pairs (RHAG/Rhag and
RHCED/Rhced) and two nonerythroid gene pairs
(RHCG/Rhcg and RHBG/Rhbg). Notably, all the
RH loci harbor single copy genes, except for human
RHCED (37), and all have a different map location, although
each orthologous group shows comparable chromosomal synteny. By
contrast, there is only one Rh gene in the unicellular organism slime
mold (2), two tightly linked copies in C. elegans (15), and
three discrete members in the zebrafish.2 These
observations suggest that both the erythroid and nonerythroid branches
came into existence before mammalian radiation and that their
multiplicity occurred mainly via intergenic translocation events. This
pattern of RH duplication is likely to have produced functional novelty in a different temporal and spatial context within
the organism, given changes in both coding sequence and regulatory
elements of the gene (5-7, 10-12, 32-34).
Compared with erythroid homologues, both primitive and nonerythroid
members, including RhCG and Rhcg, are structurally much closer to
RhAG/Rhag than they are to RhCED/Rhced. By excluding the more distant
RhCED/Rhced group, a membrane fold has been identified, which is
characterized by shared signatures conserved among human/mouse RhCG/Rhcg, RhBG/Rhbg, and RhAG/Rhag pairs. This relationship conforms to the approximate equidistance between the erythroid and nonerythroid branches and extends the observation that the RHCED series
originated from an Rhag ancestor gene but evolved at a much
increased rate (11, 38). The slower divergence of RHAG and
the faster evolution of RHCED imply an adapted functional
specification that pertains to Rh complex assembly in the RBC membrane
through heteromeric interactions. These interactions are likely
mediated by both N- and C-terminal domains and involve hydrophobic
contacts between RhAG and RhCED (39-41). Without RhAG expression, as
observed in the regulator type of Rhnull disease (40, 41),
the RhCE/D proteins and their associated antigens are not dispositioned
at the cell surface. In sharp contrast, such heteromeric interaction is
not a prerequisite for surface expression of RhCG, as RhCG could by
itself reach the plasma membrane, whether transfected into homologous
or heterologous cells. Most likely, nonerythroid Rh homologues possess
intrinsic topogenic signal sequences that can direct their own
intracellular transport and plasma membrane destination. Further
studies are required to determine whether RhCG/Rhcg is on apical or
basal membrane in the cells.
Besides their capability of being expressed in heterologous cells, RhCG
and Rhcg differ from erythroid members in the following features. 1)
They each have a larger exoloop 6 and much longer cytoplasmic
C-terminal sequence that is rich in Pro and Ser residues. This novel
C-terminal domain may be involved in functional modulation of RhCG or
Rhcg through interactions with some yet-to-be recognized intracellular
proteins. 2) RHCG/Rhcg is unique, having a
CpG island-rich promoter and an extra 3'-UTR exon, suggesting a
different mode in controlling tissue-specific expression. 3) The human
RHCG gene is mapped at 15q25 and close to the type I
tyrosinemia disease locus (42), although its phenotypic relationship
with the latter is unknown. 4) The onset of Rhcg expression
occurs very late in development, contrary to the early coexpression of
Rhag and Rhced that parallels erythroid
differentiation at embryonic stages (12). 5) Compared with the
erythroid restriction of Rhag/Rhced (12), RHCG or
Rhcg is abundantly and broadly expressed in the kidney and
in the testis. 6) Although residing in the plasma membrane, as
erythroid Rh proteins, Rhcg is concentrated in the epithelial linings
of the tubular structures, the kidney collecting tubules, and the
testis seminiferous tubules. These features suggest new testable
hypotheses as to the function of RhCG/Rhcg, possibly acting as a
previously unrecognized transporter across the plasma membrane of
epithelial cells.
Rh proteins have long been thought to possess a transport activity due
to their characteristic TM fold and associated morphological and
physiological changes in Rhnull disease (2, 7). However, their ligand(s) has not been identified, and their functional dependence on the assembly of a heteromeric complex between RhAG and
RhCED remains to be established. Prior studies suggested that Rh might
function as an ATP-dependent phosphatidylserine transporter (phosphatidylserine flipase) of the RBC membrane (43, 44). Nonetheless,
two lines of evidence disfavor this proposal: 1) Rh proteins lack the
ATP-binding cassette (ABC) (2, 7); and 2) Rhnull cells have
a normal phosphatidylserine transport activity (45).
Recently, a relationship between erythroid Rh proteins and
NH4+ transporters of the Mep/Amt family
has been suggested based on marginal sequence identity (11.1-17.7%)
(9). RhCG/Rhcg and other nonerythroid homologues lie in the same range
of identity with these transporters. Although
NH4+ transporters are found in all three
domains of life (9), Rh family members occur only in Eucarya
(2). In Eucarya, Mep/Amt members occur in yeast (46),
plants (47), and nematodes (14), but not other animals; in contrast, Rh
homologues are present in animals (10) and slime mold (2) but absent in
yeast and plants, except algae.2 The sequence connection,
along with the tissue specificity, raises the possibility that RhCG and
Rhcg occur as potential NH4+
transporters in kidney and testis. However, it should be noted that the
homology between RhCG/Rhcg and Mep/Amt proteins is quite dispersed and
only distantly related. This evolutionary distance could be large
enough to endow RhCG/Rhcg with a pivotal structural difference in
functional specification. Furthermore, evolution economy also argues
against the coexistence of two Rh homologues and three Mep/Amt proteins
as the same functional duplicates that all transport
NH4+ in C. elegans (14).
Finally, the topology of RhCG/Rhcg resembles numerous 12-TM
transporters lacking an ABC domain (8) but differs from that of Mep/Amt
members, which generally contain 10 TM helical domains (46-48). If the
spatially conserved amino acids are to form a binding site for the
amino group only, RhCG or Rhcg may serve to transport some novel amines
rather than ammonium itself. The conserved structure and abundant
expression suggest that RhCG and Rhcg play an essential role in
maintaining normal homeostatic conditions in kidney and testis. In
future work, it will thus be important to examine the above hypotheses
using models amenable to biochemical and physiological manipulations.
To this end, the transient and stable expression systems described here
should serve as useful tools for the functional identification of both erythroid and nonerythroid Rh family proteins.
 |
ACKNOWLEDGEMENTS |
We are grateful to Michael Cammer (Director
of Imaging Analysis at the Albert Einstein College of Medicine) for
confocal microscopy and to Mary Barter (The Jackson Laboratory) for
Fig. 4B. We appreciate Jianbin Peng's assistance in
computer analysis and figure illustrations and staff members of the
Laboratory of Microchemistry for DNA sequencing. Thanks are also due to
Drs. Olga Blumenfeld and Colvin Redman for helpful comments.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant HL54459 (to C.-H. H.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF193807, AF193808, AF193809, AF193810, AF183390, AF183391,
AF193811, AF193812, AF209468, AF219981 to AF219986, and AF238372 to
AF238377.
To whom correspondence should be addressed: Laboratory of
Biochemistry and Molecular Genetics, Lindsley F. Kimball Research Inst., New York Blood Center, 310 East 67th St., New York, NY 10021.
Tel: 212-570-3388; Fax: 212-570-3251; E-mail: chuang@nybc.org.
Published, JBC Papers in Press, June 13, 2000, DOI 10.1074/jbc.M003353200
2
Z. Liu and C.-H. Huang, unpublished observations.
3
Z. Liu and C.-H. Huang, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
RBC, red blood cell;
TM, transmembrane;
GSP, gene-specific primer;
RACE, rapid amplification
of cDNA ends;
PCR, polymerase chain reaction;
GFP, green
fluorescence protein;
BAC, bacterial artificial chromosome;
PAGE, polyacrylamide gel electrophoresis;
nt, nucleotide;
bp, base pair(s);
kb, kilobase(s);
UTR, untranslated region;
CPMM, canine pancreatic
microsomal membranes.
 |
REFERENCES |
| 1.
|
Mollison, P. L.,
Engelfriet, C. P.,
and Contreras, M.
(1997)
Blood Transfusion in Clinical Medicine
, Blackwell Science, Oxford, England
|
| 2.
|
Huang, C.-H.,
Liu, Z.,
and Cheng, G.
(2000)
Semin. Hematol.
34,
150-165
|
| 3.
|
Cherif-Zahar, B.,
Mattei, M.-G.,
Le Van Kim, C.,
Bailly, P.,
Cartron, J.-P.,
and Colin, Y.
(1991)
Hum. Genet.
86,
398-400
|
| 4.
|
Ridgwell, K.,
Spurr, N. K.,
Laguda, B.,
MacGeoch, C.,
Avent, N. D.,
and Tanner, M. J. A.
(1992)
Biochem. J.
287,
223-228
|
| 5.
|
Huang, C.-H.
(1998)
J. Biol. Chem.
273,
2207-2213
|
| 6.
|
Matassi, G.,
Chérif-Zahar, B.,
Raynal, V.,
Rouger, P.,
and Cartron, J.-P.
(1998)
Genomics
47,
286-293
|
| 7.
|
Agre, P.,
and Cartron, J.-P.
(1991)
Blood
78,
551-563
|
| 8.
|
Henderson, P. J.
(1993)
Curr. Opin. Cell Biol.
5,
708-721
|
| 9.
|
Marini, A. M.,
Urrestarazu, A.,
Beauwens, R.,
and Andre, B.
(1997)
Trends Biochem. Sci.
22,
460-461
|
| 10.
|
Blancher, A.,
and Socha, W. W.
(1997)
in
Molecular Biology and Evolution of Blood Group and MHC Antigens in Primates
(Blancher, A.
, Klein, J.
, and Socha, W. W., eds)
, pp. 147-218, Springer Verlag, Heidelberg
|
| 11.
| Huang, C.-H., Liu, Z., Apoil, P.-A., and Blancher, A. (2000) J. Mol. Evol., in press
|
| 12.
|
Liu, Z.,
and Huang, C.-H.
(1999)
Biochem. Genet.
37,
119-138
|
| 13.
|
Seack, J.,
Pancer, Z.,
Muller, I. M.,
and Muller, W. E.
(1997)
Immunogenetics
46,
493-498
|
| 14.
|
Wilson, R.,
Ainscough, R.,
Anderson, K.,
Baynes, C.,
Berks, M.,
Bonfield, J.,
Burton, J.,
Connell, M.,
Copsey, T.,
Cooper, J.,
et al..
(1994)
Nature
368,
32-38
|
| 15.
|
Huang, C.-H.,
Liu, Z.,
Cheng, G. J.,
and Chen, Y.
(1998)
Blood
92,
1776-1784
|
| 16.
|
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402
|
| 17.
|
Frohman, M. A.,
Dush, M. K.,
and Martin, G. R.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8998-9002
|
| 18.
|
Sambrook, J.,
Fristch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 19.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680
|
| 20.
|
Kyte, J.,
and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132
|
| 21.
|
Harlow, E.,
and Lane, D.
(1988)
Antibodies: A Laboratory Manual
, 1st Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 22.
|
Heng, H. H. Q.,
Squire, J.,
and Tsui, L.-C.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
9509-9513
|
| 23.
|
Rowe, L. B.,
Nadeau, J. H.,
Turner, R.,
Frankel, W. N.,
Letts, V. A.,
Eppig, J. T.,
Ko, M. S. H.,
Thurston, S. J.,
and Birkenmeier, E. H.
(1994)
Mamm. Genome
5,
253-274
|
| 24.
|
Hui, C.-c.,
and Joyner, A. L.
(1993)
Nat. Genet.
3,
241-246
|
| 25.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 26.
|
Fong, A. D.,
Handlogten, M. E.,
and Kilberg, M. S.
(1990)
Biochim. Biophys. Acta
1022,
325-332
|
| 27.
|
Huang, C.-H.,
Blumenfeld, O. O.,
Reid, M. E.,
Chen, Y.,
Daniels, G. L.,
and Smart, E.
(1997)
Blood
90,
391-397
|
| 28.
|
Kozak, M.
(1987)
Nucleic Acids Res.
15,
8125-8148
|
| 29.
|
Chumakov, I. M.,
Rigault, P.,
Le Gall, I.,
Bellanne-Chantelot, C.,
Billault, A.,
Guillou, S.,
Soularue, P.,
Guasconi, G.,
Poullier, E.,
Gros, I.,
et al..
(1995)
Nature
377 (suppl.),
175-297
|
| 30.
|
Shapiro, M. B.,
and Senapathy, P.
(1987)
Nucleic Acids Res.
15,
7155-7174
|
| 31.
|
Gardiner-Garden, M.,
and Frommer, M.
(1987)
J. Mol. Biol.
196,
261-282
|
| 32.
|
Cherif-Zahar, B.,
Le Van Kim, C.,
Rouillac, C.,
Raynal, V.,
Cartron, J.-P.,
and Colin, Y.
(1994)
Genomics
19,
68-74
|
| 33.
|
Huang, C.-H.
(1996)
Blood
88,
2326-2333
|
| 34.
|
Iwamoto, S.,
Omi, T.,
Yamasaki, M.,
Okuda, H.,
Kawano, M.,
and Kajii, E.
(1998)
Biochem. Biophys. Res. Commun.
243,
233-240
|
| 35.
|
Fawcett, D. W.,
and Raviola, E.
(1994)
A Text Book of Histology
, 12th Ed.
, Chapman & Hall, New York
|
| 36.
|
Moore, S.,
Woodrow, C. F.,
and McClelland, D. B. L.
(1982)
Nature
295,
529-531
|
| 37.
|
Carritt, B.,
Kemp, T. J.,
and Poulter, M.
(1997)
Hum. Mol. Genet.
6,
843-850
|
| 38.
|
Kitano, T.,
Sumiyama, K.,
Shiroishi, T.,
and Saitou, N.
(1998)
Biochem. Biophys. Res. Commun.
249,
78-85
|
| 39.
|
Ridgwell, K.,
Eyers, S. A.,
Mawby, W. J.,
Anstee, D. J.,
and Tanner, M. J.
(1994)
J. Biol. Chem.
269,
6410-6416
|
| 40.
|
Huang, C.-H.,
Cheng, G.-J.,
Liu, Z.,
Chen, Y.,
Reid, M. E.,
Halverson, G.,
and Okubo, Y.
(1999)
Am. J. Hematol.
62,
25-32
|
| 41.
|
Cherif-Zahar, B.,
Raynal, V.,
Gane, P.,
Mattei, M.-G.,
Bailly, P.,
Gibbs, B.,
Colin, Y.,
and Cartron, J.-P.
(1996)
Nat. Genet.
12,
168-173
|
| 42.
|
McKusick, V. A.
(1999)
The Human Genome Database Project
, Johns Hopkins University, Baltimore, MDOnline Mendelian Inheritance in Man
|
| 43.
|
Connor, J.,
and Schroit, A. J.
(1988)
Biochemistry
27,
848-851
|
| 44.
|
Schroit, A. J.,
Bloy, C.,
Conner, J.,
and Cartron, J.-P.
(1990)
Biochemistry
29,
10303-10306
|
| 45.
|
Smith, R. E.,
and Dalek, D. L.
(1990)
Blood
76,
1021-1027
|
| 46.
|
Marini, A. M.,
Soussi-Boudekou, S.,
Vissers, S.,
and Andre, B.
(1997)
Mol. Cell. Biol.
17,
4282-4293
|
| 47.
|
Kaiser, B. N.,
Finnegan, P. M.,
Tyerman, S. D.,
Whitehead, L. F.,
Bergersen, F. J.,
Day, D. A.,
and Udvardi, M. K.
(1998)
Science
281,
1202-1206
|
| 48.
|
Bult, C. J.,
White, O.,
Olsen, G. J.,
Zhou, L.,
Fleischmann, R. D.,
Sutton, G. G.,
Blake, J. A.,
Fitzgerald, L. M.,
Clayton, R. A.,
Gocayne, J. D.,
et al..
(1996)
Science
273,
1058-1073
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K.-H. Han, K. Mekala, V. Babida, H.-Y. Kim, M. E. Handlogten, J. W. Verlander, and I. D. Weiner
Expression of the gas-transporting proteins, Rh B glycoprotein and Rh C glycoprotein, in the murine lung
Am J Physiol Lung Cell Mol Physiol,
July 1, 2009;
297(1):
L153 - L163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Weihrauch, M. P. Wilkie, and P. J. Walsh
Ammonia and urea transporters in gills of fish and aquatic crustaceans
J. Exp. Biol.,
June 1, 2009;
212(11):
1716 - 1730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-W. Lee, J. W. Verlander, J. M. Bishop, P. Igarashi, M. E. Handlogten, and I. D. Weiner
Collecting duct-specific Rh C glycoprotein deletion alters basal and acidosis-stimulated renal ammonia excretion
Am J Physiol Renal Physiol,
June 1, 2009;
296(6):
F1364 - F1375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. N. Brown, D. Hallouane, W. J. Mawby, F. E. Karet, M. A. Saleem, A. J. Howie, and A. M. Toye
RhCG is the major putative ammonia transporter expressed in the human kidney, and RhBG is not expressed at detectable levels
Am J Physiol Renal Physiol,
June 1, 2009;
296(6):
F1279 - F1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. N. Tsui, C. Y. C. Hung, C. M. Nawata, J. M. Wilson, P. A. Wright, and C. M. Wood
Ammonia transport in cultured gill epithelium of freshwater rainbow trout: the importance of Rhesus glycoproteins and the presence of an apical Na+/NH4+ exchange complex
J. Exp. Biol.,
March 15, 2009;
212(6):
878 - 892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Kim, J. W. Verlander, J. M. Bishop, B. D. Cain, K.-H. Han, P. Igarashi, H.-W. Lee, M. E. Handlogten, and I. D. Weiner
Basolateral expression of the ammonia transporter family member Rh C glycoprotein in the mouse kidney
Am J Physiol Renal Physiol,
March 1, 2009;
296(3):
F543 - F555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Yoshihara, K. Inoue, D. Schichnes, S. Ruzin, W. Inwood, and S. Kustu
An Rh1-GFP Fusion Protein Is in the Cytoplasmic Membrane of a White Mutant Strain of Chlamydomonas reinhardtii
Mol Plant,
November 14, 2008;
(2008)
ssn074v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Feller, A. M. Simpson, M. Nelson, M. A. Swan, P. J. O'Connell, W. J. Hawthorne, C. Tao, and B. A. O'Brien
Growth-Promoting Effect of Rh(D) Antibody on Human Pancreatic Islet Cells
J. Clin. Endocrinol. Metab.,
September 1, 2008;
93(9):
3560 - 3567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Nawata, C. C. Y. Hung, T. K. N. Tsui, J. M. Wilson, P. A. Wright, and C. M. Wood
Ammonia excretion in rainbow trout (Oncorhynchus mykiss): evidence for Rh glycoprotein and H+-ATPase involvement
Physiol Genomics,
November 14, 2007;
31(3):
463 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. C. Hung, K. N. T. Tsui, J. M. Wilson, C. M. Nawata, C. M. Wood, and P. A. Wright
Rhesus glycoprotein gene expression in the mangrove killifish Kryptolebias marmoratus exposed to elevated environmental ammonia levels and air
J. Exp. Biol.,
July 15, 2007;
210(14):
2419 - 2429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Khademi and R. M. Stroud
The Amt/MEP/Rh Family: Structure of AmtB and the Mechanism of Ammonia Gas Conduction.
Physiology,
December 1, 2006;
21(6):
419 - 429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Han, B. P. Croker, W. L. Clapp, D. Werner, M. Sahni, J. Kim, H.-Y. Kim, M. E. Handlogten, and I. D. Weiner
Expression of the Ammonia Transporter, Rh C Glycoprotein, in Normal and Neoplastic Human Kidney
J. Am. Soc. Nephrol.,
October 1, 2006;
17(10):
2670 - 2679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Yang, D. Zhao, E. Solenov, and A. S. Verkman
Evidence from knockout mice against physiologically significant aquaporin 8-facilitated ammonia transport
Am J Physiol Cell Physiol,
September 1, 2006;
291(3):
C417 - C423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Ji, S. Hashmi, Z. Liu, J. Zhang, Y. Chen, and C.-H. Huang
CeRh1 (rhr-1) is a dominant Rhesus gene essential for embryonic development and hypodermal function in Caenorhabditis elegans
PNAS,
April 11, 2006;
103(15):
5881 - 5886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-O. D. Mak, B. Dang, I. D. Weiner, J. K. Foskett, and C. M. Westhoff
Characterization of ammonia transport by the kidney Rh glycoproteins RhBG and RhCG
Am J Physiol Renal Physiol,
February 1, 2006;
290(2):
F297 - F305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Seshadri, J. D. Klein, S. Kozlowski, J. M. Sands, Y.-H. Kim, K.-H. Han, M. E. Handlogten, J. W. Verlander, and I. D. Weiner
Renal expression of the ammonia transporters, Rhbg and Rhcg, in response to chronic metabolic acidosis
Am J Physiol Renal Physiol,
February 1, 2006;
290(2):
F397 - F408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Huang and J. Peng
Evolutionary conservation and diversification of Rh family genes and proteins
PNAS,
October 25, 2005;
102(43):
15512 - 15517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Handlogten, S.-P. Hong, L. Zhang, A. W. Vander, M. L. Steinbaum, M. Campbell-Thompson, and I. D. Weiner
Expression of the ammonia transporter proteins Rh B glycoprotein and Rh C glycoprotein in the intestinal tract
Am J Physiol Gastrointest Liver Physiol,
May 1, 2005;
288(5):
G1036 - G1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lopez, S. Metral, D. Eladari, S. Drevensek, P. Gane, R. Chambrey, V. Bennett, J.-P. Cartron, C. Le Van Kim, and Y. Colin
The Ammonium Transporter RhBG: REQUIREMENT OF A TYROSINE-BASED SIGNAL AND ANKYRIN-G FOR BASOLATERAL TARGETING AND MEMBRANE ANCHORAGE IN POLARIZED KIDNEY EPITHELIAL CELLS
J. Biol. Chem.,
March 4, 2005;
280(9):
8221 - 8228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Nakhoul, H. DeJong, S. M. Abdulnour-Nakhoul, E. L. Boulpaep, K. Hering-Smith, and L. L. Hamm
Characteristics of renal Rhbg as an NH4+ transporter
Am J Physiol Renal Physiol,
January 1, 2005;
288(1):
F170 - F181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zheng, D. Kostrewa, S. Berneche, F. K. Winkler, and X.-D. Li
The mechanism of ammonia transport based on the crystal structure of AmtB of Escherichia coli
PNAS,
December 7, 2004;
101(49):
17090 - 17095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ripoche, O. Bertrand, P. Gane, C. Birkenmeier, Y. Colin, and J.-P. Cartron
Human Rhesus-associated glycoprotein mediates facilitated transport of NH3 into red blood cells
PNAS,
December 7, 2004;
101(49):
17222 - 17227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Wagner, K. E. Finberg, S. Breton, V. Marshansky, D. Brown, and J. P. Geibel
Renal Vacuolar H+-ATPase
Physiol Rev,
October 1, 2004;
84(4):
1263 - 1314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Handlogten, S.-P. Hong, C. M. Westhoff, and I. D. Weiner
Basolateral ammonium transport by the mouse inner medullary collecting duct cell (mIMCD-3)
Am J Physiol Renal Physiol,
October 1, 2004;
287(4):
F628 - F638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cheval, J. P. Duong Van Huyen, P. Bruneval, J.-M. Verbavatz, J.-M. Elalouf, and A. Doucet
Plasticity of mouse renal collecting duct in response to potassium depletion
Physiol Genomics,
September 16, 2004;
19(1):
61 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Ludewig
Electroneutral ammonium transport by basolateral rhesus B glycoprotein
J. Physiol.,
September 15, 2004;
559(3):
751 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. K. Johansson, J. Brodd, C. Eklof, M. Ferletta, G. Hesselager, C.-F. Tiger, L. Uhrbom, and B. Westermark
Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging
PNAS,
August 3, 2004;
101(31):
11334 - 11337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Westhoff, D. L. Siegel, C. G. Burd, and J. K. Foskett
Mechanism of Genetic Complementation of Ammonium Transport in Yeast by Human Erythrocyte Rh-associated Glycoprotein
J. Biol. Chem.,
April 23, 2004;
279(17):
17443 - 17448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bakouh, F. Benjelloun, P. Hulin, F. Brouillard, A. Edelman, B. Cherif-Zahar, and G. Planelles
NH3 Is Involved in the NH4 Transport Induced by the Functional Expression of the Human Rh C Glycoprotein
J. Biol. Chem.,
April 16, 2004;
279(16):
15975 - 15983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Quentin, D. Eladari, L. Cheval, C. Lopez, D. Goossens, Y. Colin, J.-P. Cartron, M. Paillard, and R. Chambrey
RhBG and RhCG, the Putative Ammonia Transporters, Are Expressed in the Same Cells in the Distal Nephron
J. Am. Soc. Nephrol.,
March 1, 2003;
14(3):
545 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Verlander, R. T. Miller, A. E. Frank, I. E. Royaux, Y.-H. Kim, and I. D. Weiner
Localization of the ammonium transporter proteins RhBG and RhCG in mouse kidney
Am J Physiol Renal Physiol,
February 1, 2003;
284(2):
F323 - F337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Eladari, L. Cheval, F. Quentin, O. Bertrand, I. Mouro, B. Cherif-Zahar, J.-P. Cartron, M. Paillard, A. Doucet, and R. Chambrey
Expression of RhCG, a New Putative NH3/NH4+ Transporter, along the Rat Nephron
J. Am. Soc. Nephrol.,
August 1, 2002;
13(8):
1999 - 2008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Soupene, N. King, E. Feild, P. Liu, K. K. Niyogi, C.-H. Huang, and S. Kustu
Rhesus expression in a green alga is regulated by CO2
PNAS,
May 28, 2002;
99(11):
7769 - 7773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Westhoff, M. Ferreri-Jacobia, D.-O. D. Mak, and J. K. Foskett
Identification of the Erythrocyte Rh Blood Group Glycoprotein as a Mammalian Ammonium Transporter
J. Biol. Chem.,
April 5, 2002;
277(15):
12499 - 12502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Liu and S. E. Wilson
Characterization of Human and Mouse Angiopoietin-like Factor CDT6 Promoters
Invest. Ophthalmol. Vis. Sci.,
November 1, 2001;
42(12):
2776 - 2783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Soupene, R. M. Ramirez, and S. Kustu
Evidence that Fungal MEP Proteins Mediate Diffusion of the Uncharged Species NH3 across the Cytoplasmic Membrane
Mol. Cell. Biol.,
September 1, 2001;
21(17):
5733 - 5741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Liu, J. Peng, R. Mo, C.-c. Hui, and C.-H. Huang
Rh Type B Glycoprotein Is a New Member of the Rh Superfamily and a Putative Ammonia Transporter in Mammals
J. Biol. Chem.,
January 5, 2001;
276(2):
1424 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|